Friday, December 04, 2015
Biogen's CEO and Cornell alumnus George Scangos visited Cornell at the invitation of Alumni Affairs and Development. The talk was moderated by Provost Michael Kotlikoff, former Dean of the Veterinary School. His videotaped talk "Risk/Reward in Biotechnology: Can We Afford to Innovate ?" is now available via CornellCast.
About the video:
Biogen CEO Dr. George A. Scangos ’70 presents an overview of the company's business model, drug development and strategy for future innovation, as well as a discussion of pricing and financial returns for biotechnology companies and the expectations of patients, physicians, investors and politicians.
Biogen is a global biotechnology company that specializes in the discovery, development and delivery of therapies for the treatment of neurodegenerative, hematologic and autoimmune diseases. Scangos is chairman-elect of the Board of Directors of Pharmaceutical Research and Manufacturers of America (PhRMA).
|See http://www.cornell.edu/video/biogen-ceo-george-scangos-risk-reward-biotechnology-innovation for more information.|